Gambichler, T.; Stang, A.; Mansour, R.; Scheel, C.H.; Nick, C.; Abu Rached, N.; Becker, J.C.; Susok, L.
Prognostic Potential of the Baseline Pan-Immune-Inflammation Value and Neutrophil/Lymphocyte Ratio in Stage I to III Melanoma Patients. Cancers 2022, 14, 4410.
https://doi.org/10.3390/cancers14184410
AMA Style
Gambichler T, Stang A, Mansour R, Scheel CH, Nick C, Abu Rached N, Becker JC, Susok L.
Prognostic Potential of the Baseline Pan-Immune-Inflammation Value and Neutrophil/Lymphocyte Ratio in Stage I to III Melanoma Patients. Cancers. 2022; 14(18):4410.
https://doi.org/10.3390/cancers14184410
Chicago/Turabian Style
Gambichler, Thilo, Andreas Stang, Rita Mansour, Christina H. Scheel, Celine Nick, Nessr Abu Rached, Jürgen C. Becker, and Laura Susok.
2022. "Prognostic Potential of the Baseline Pan-Immune-Inflammation Value and Neutrophil/Lymphocyte Ratio in Stage I to III Melanoma Patients" Cancers 14, no. 18: 4410.
https://doi.org/10.3390/cancers14184410
APA Style
Gambichler, T., Stang, A., Mansour, R., Scheel, C. H., Nick, C., Abu Rached, N., Becker, J. C., & Susok, L.
(2022). Prognostic Potential of the Baseline Pan-Immune-Inflammation Value and Neutrophil/Lymphocyte Ratio in Stage I to III Melanoma Patients. Cancers, 14(18), 4410.
https://doi.org/10.3390/cancers14184410